Clinical Trial Detail

NCT ID NCT01847274
Title A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Tesaro, Inc.
Indications

fallopian tube cancer

peritoneum cancer

ovarian cancer

Therapies

Niraparib

Age Groups: adult

No variant requirements are available.